4.7 Article

Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2-positive breast cancer

Related references

Note: Only part of the references are listed.
Review Medical Laboratory Technology

Neuromedin U: A Multifunctional Neuropeptide with Pleiotropic Roles

Vanesa G. Martinez et al.

CLINICAL CHEMISTRY (2015)

Review Immunology

Versatile functions for IL-6 in metabolism and cancer

Jan Mauer et al.

TRENDS IN IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity

Christine L. Chaffer et al.

Article Cell Biology

The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells

Javier A. Menendez et al.

CELL CYCLE (2013)

Review Cell Biology

Targeting cellular metabolism to improve cancer therapeutics

Y. Zhao et al.

CELL DEATH & DISEASE (2013)

Article Cardiac & Cardiovascular Systems

Energy metabolism plasticity enables stemness programs

Clifford D. L. Folmes et al.

EVOLVING CHALLENGES IN PROMOTING CARDIOVASCULAR HEALTH (2012)

Article Biochemistry & Molecular Biology

Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death

Nicholas A. Graham et al.

MOLECULAR SYSTEMS BIOLOGY (2012)

Article Biochemistry & Molecular Biology

The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells

Kakajan Komurov et al.

MOLECULAR SYSTEMS BIOLOGY (2012)

Review Cell Biology

Metabolic Flux and the Regulation of Mammalian Cell Growth

Jason W. Locasale et al.

CELL METABOLISM (2011)

Article Multidisciplinary Sciences

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

Dimitrios Iliopoulos et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Pathology

Cancer metabolism: The Warburg effect today

Leonardo M. R. Ferreira

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)

Article Multidisciplinary Sciences

TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

Zhan Yao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells

Matthew G. Vander Heiden et al.

SCIENCE (2010)

Article Biochemistry & Molecular Biology

Nmur1-/- mice are not protected from cutaneous inflammation

Susan J. Abbondanzo et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Review Pharmacology & Pharmacy

Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

J. D. Mitchell et al.

BRITISH JOURNAL OF PHARMACOLOGY (2009)

Review Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transitions in Development and Disease

Jean Paul Thiery et al.

Article Biochemistry & Molecular Biology

Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells

N. J. Sullivan et al.

ONCOGENE (2009)

Article Multidisciplinary Sciences

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Chad J. Creighton et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

The epithelial-mesenchymal transition generates cells with properties of stem cells

Sendurai A. Mani et al.

Article Biochemistry & Molecular Biology

Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance

Chun-Wun Lu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock

M Moriyama et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Immunology

Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1

EN Johnson et al.

JOURNAL OF IMMUNOLOGY (2004)